This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Genfleet Therapeutics (Shanghai) Inc., Zhejiang Genfleet Therapeutics Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 7 
1 out of 2 Years Active: 2026
Title: Xiaoling Lan - Innovator in Pharmaceutical Compounds
Introduction
Xiaoling Lan is an inventor based in Shanghai, CN. He is known for his contributions to the field of pharmaceutical compounds, particularly in the development of innovative tricyclic and heterocyclic compounds. Although he currently holds no granted patents, his work in patent applications demonstrates his commitment to advancing medical science.
Latest Patent Applications
Xiaoling Lan has filed several notable patent applications. One of his latest applications is for an aroyl substituted tricyclic compound, which includes a preparation method and its use. This compound serves as a BTK inhibitor, showcasing high activity, good selectivity, and low toxicity. Another significant application involves a fused ring substituted six-membered heterocyclic compound, which exhibits HPK1 inhibitory activity. This compound, along with its pharmaceutically acceptable salts and derivatives, is aimed at preventing and treating diseases associated with HPK1 activity.
Conclusion
Xiaoling Lan is an emerging inventor whose latest patent applications reflect his innovative approach to pharmaceutical development. His work has the potential to contribute significantly to medical advancements in the future.